S-EPMC4652496 - Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guerin (BCG) - OmicsDI

Unknown

Dataset Information

Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guerin (BCG)

ABSTRACT:

SUBMITTER: Steinberg G

PROVIDER: S-EPMC4652496 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature